Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
89
Views
5
CrossRef citations to date
0
Altmetric
Original Research

lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance

Mao CaiDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
,
Wanle HuDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
,
Chongjie HuangDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
,
Chongjun ZhouDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
,
Jiante LiDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
,
Yanyu ChenDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of China
&
Yaojun YuDepartment of Anorectal Surgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0829-4715
ORCID Icon show all
Pages 8685-8694 | Published online: 19 Nov 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Qing She, Yuanyuan Chen, Hong Liu, Jichao Tan & Youhuai Li. (2022) A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis. Bioengineered 13:5, pages 13437-13451.
Read now

Articles from other publishers (4)

Mehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi, Sadaf Gholami, Rasoul Raesi, Seyed Shahabadin Bidoki, Mohammad Ali Sheikh Beig Goharrizi, Yasamin Sadat Mousavi Motlagh, Ramin Khorrami, Alireza Tavakolpournegari, Noushin Nabavi, Rongjun Zou, Leila Mohammadnahal, Maliheh Entezari, Afshin Taheriazam & Kiavash Hushmandi. (2024) Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. Translational Oncology 40, pages 101846.
Crossref
Feng Liu, Yutingzi Wang, Yang Cao, Zhiwei Wu, De Ma, Jun Cai, Jie Sha & Qing Chen. (2023) Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer. Chemico-Biological Interactions 374, pages 110412.
Crossref
Jiaqi Liu, Yuexia Meng, Bihui Li, Pin Wang, Xiaowei Wan, Wenjun Huang & Rong Li. (2022) Ferroptosis-related biotargets and network mechanisms of fucoidan against colorectal cancer: An integrated bioinformatic and experimental approach. International Journal of Biological Macromolecules 222, pages 1522-1530.
Crossref
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, Shayan Fallah, Arezoo Sanaei, Elahe Sadat Hejazi, Amirabbas Kakavand, Shamin Rezaei, Hajar Heidari, Mitra Behroozaghdam, Salman Daneshi, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi & Saeed Samarghandian. (2022) LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy 154, pages 113609.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.